The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission
Open accessAbstract
Cannabinoids are the most popular illicit drugs used for recreational purposes worldwide. However, the neurobiological substrate of their mood-altering capacity has not been elucidated so far. Here we report that CB1 cannabinoid receptors are expressed at high levels in certain amygdala nuclei, especially in the lateral and basal nuclei, but are absent in other nuclei (e.g., in the central nucleus and in the medial nucleus). Expression of the CB1 protein was restricted to a distinct subpopulation of GABAergic interneurons corresponding to large cholecystokinin-positive cells. Detailed electron microscopic investigation revealed that CB1 receptors are located presynaptically on cholecystokinin-positive axon terminals, which establish symmetrical GABAergic synapses with their postsynaptic targets. The physiological consequence of this particular anatomical localization was investigated by whole-cell patch-clamp recordings in principal cells of the lateral and basal nuclei. CB1 receptor agonists WIN 55,212-2 and CP 55,940 reduced the amplitude of GABA(A) receptor-mediated evoked and spontaneous IPSCs, whereas the action potential-independent miniature IPSCs were not significantly affected. In contrast, CB1 receptor agonists were ineffective in changing the amplitude of IPSCs in the rat central nucleus and in the basal nucleus of CB1 knock-out mice. These results suggest that cannabinoids target specific elements in neuronal networks of given amygdala nuclei, where they presynaptically modulate GABAergic synaptic transmission. We propose that these anatomical and physiological features, characteristic of CB1 receptors in several forebrain regions, represent the neuronal substrate for endocannabinoids involved in retrograde synaptic signaling and may explain some of the emotionally relevant behavioral effects of cannabinoid exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following their synthesis, ECBs are retrogradely transported into the extracellular space to bind ECB receptors present on presynaptic terminals [19–21].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [19]
In the citing paper
“Within amygdala subnuclei, FAAH is highly expressed on pyramidal neurons in the BLA, and to a significantly lesser extent in the central nucleus (CeA) [19,20,46,47].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [19]
In the citing paper
“Yet, CB1 receptors are expressed at high levels in the BLA (Herkenham et al, 1990;Katona et al, 2001;Tsou et al, 1997)”
From Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (2012) · cites this paper as Katona et al, 2001
In the citing paper
“but their expression in the central amygdala is less clear (Katona et al, 2001;Tsou et al, 1997;Cota et al, 2007; but see Kamprath et al, 2011).”
From Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (2012) · cites this paper as Katona et al, 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,078
Marsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Kreitzer, A. C., & Regehr, W. G. (2001) · Neuron · doi:10.1016/s0896-6273(01)00246-x · Cited by 899
Ohno‐Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 874
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 660
Cited by
Sorted by citations
Items 601–663 of 663
A REPRODUKCIÓT SZABÁLYOZÓ HIPOTALAMIKUS NEURONHÁLÓZAT MORFOLÓGIAI ÉS FUNKCIONÁLIS JELLEMZÉSE
Hrabovszky, E. (2010) · REAL-d (Hungarian Academy of Sciences)
NEUROFUNCTIONAL DEFICITS DURING DECISION-MAKING AND AFFECTIVE PROCESSING IN CHRONIC MARIJUANA USERS
Wesley, M. J. (2010) · WakeSpace Scholarship (Wake Forest University)
The Relaxation System Theoretical Construct
Wisneski, L., & Wisneski, L. (2017) · CRC Press eBooks · doi:10.1201/9781315153889-5
Review on Amygdala Neural Circuitry of Antinociception: On Actions of Opioids and Endocannabinoids
MaengSikShin (2010) · 한국심리학회지: 인지 및 생물 · doi:10.22172/cogbio.2010.22.3.008
Ladarré, D., & Lenkei, Z. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_4
Kupferschmidt, D. A. (2012) · TSpace (University of Toronto)
Benevenuto, S. G. D. M. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2016.tde-04102016-125441
An integrative overview of the cannabinergic system and mental health
Prospero-Garcia, O. E., Laboratorio de Cannabinoides, D. D. F., Rueda‐Orozco, P. E., Belmont, O. A., Ruiz‐Contreras, A. E., Méndez‐Díaz, M., Departamento de Neurofisiología del Desarrollo y Neurofisiología, I. D. N., & Laboratorio de Neurogenómica Cognitiva, C. D. P. Y. N. (2017) · Salud Mental · doi:10.17711/sm.0185-3325.2017.015
“In the amygdala it has been demonstrated that CB1 is principally in the GABAergic interneurons (Katona et al., 2001).”
BackgroundCurry, T. E. (2013) · TSpace (University of Toronto)
Genetic Neuroimaging of Social Perception
Faig, K. E., Nikolova, Y. S., & Hariri, A. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00161-5
Pereira, B. J. G. (2018) · Scholarship@Western (Western University)
Changes in the Endocannabinoid system in the Brain Following Bilateral Vestibular Damage
Baek, J. (2011) · Otago University Research Archive (University of Otago)
Exploring Novel Treatment Approaches for Post-Traumatic Stress Disorder
Murkar, A. (2020) · uO Research (University of Ottawa) · doi:10.20381/ruor-24279
“CB1 receptors are expressed in the hippocampus, basolateral and lateral amygdala, and medial prefrontal cortex (mPFC; [223]) – key regions implicated in fear learning - but are absent in the central and medial nuclei of the amygdala [231], regions involved in fear expression.”
BackgroundDopamine and Opioid regulation of amygdala function
Patel, S. (2020) · The Sydney eScholarship Repository (The University of Sydney)
A kannabinoidok hatásai és használatuk veszélyei
Szalay, K., & Emri, Z. (2020) · Acta Universitatis de Carolo Eszterházy Nominatae Sectio Biologiae · doi:10.33041/actauniveszterhazybiol.2020.45.23
(2009) · CRC Press eBooks · doi:10.1201/b10166-5
Effects of Prenatal Cannabis Exposure on Offspring Emotional Development and Stress Response
Pritchett, A. (2021) · CUNY Academic Works (City University of New York)
Soti, M., Ranjbar, H., Kohlmeier, K. A., Razavinasab, M., Masoumi‐Ardakani, Y., & Shabani, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1235620/v1
Associations Between Adolescent Cannabis Use Trajectories and Anxiety
Duperrouzel, J. C. (2019) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc008985
“The downregulation of receptors is hypothesized to exacerbate anxiety, as normal endocannabinoid signaling is disrupted (Katona et al., 2001; Martin, Ledent, Parmentier, Maldonado, & Valverde, 2002).”
BackgroundSante, S. D. (2022) · doi:10.22215/etd/2022-14843
“glutamatergic and GABAergic VTA DA neuron afferents (Katona et al., 2001).”
BackgroundPharmacological Mechanism of Paracetamol on Empathy-Like Behavior in Adult Male RatsPreprint
Kandiş, S., Koç, B., Ateş, M., Karakılıç, A., Kızıldağ, S., Güvendi, G., Gümüş, H., Tuğlu, M. İ., Hosgorler, F. U., & Uysal, N. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3935621
Parker, L. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734674759.793560175
Cannabinoid-basierte Therapie in einem Modell für die sporadische Alzheimer-Erkrankung
Sichler, M. E. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9445
Cardoso, G. K. R. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.59.2022.tde-01092022-134636
Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathyPreprint
Jahncke, J. N., Miller, D. S., Krush, M., Schnell, E., & Wright, K. M. (2023) · eLife · doi:10.7554/elife.87965.1
eLife Assessment: Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathy
Overstreet‐Wadiche, L. (2023) · eLife · doi:10.7554/elife.87965.1.sa3
The endocannabinoid system: Signaling and social motivation
Cysneiros, R. M., & Ribeiro, F. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00012-7 · Cited by 1
Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathyPreprint
Jahncke, J. N., Miller, D. S., Krush, M., Schnell, E., & Wright, K. M. (2023) · eLife · doi:10.7554/elife.87965.2
eLife Assessment: Inhibitory CCK+ basket synapse defects in mouse models of dystroglycanopathy
Overstreet‐Wadiche, L. (2023) · eLife · doi:10.7554/elife.87965.2.sa3
In vivo and in vitro assays, and safety profiles of cannabinoids
Gwedela, M. N. V., Jana, C. E., Mwambyale, T., Chikowe, I., Chimphepo, L., & Chirambo, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95927-8.00009-8
A brief review of anandamide in cannabis use and cannabis use disorder
Mahmood, R., Poluga, C., Boileau, I., & Best, L. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00009-3
Inoshita, T., & Kawaguchi, S. (2025) · eLife · doi:10.7554/elife.105268
“…of synapses in the CNS including the hippocampus, cerebellum, prefrontal cortex, amygdala, and so on Kano et al., 2009 ; Di Marzo et al., 2001 ; Katona et al., 2001 ; Hill and Patel, 2013 , which has provided basic knowledge about the primary mechanisms of cannabis intake affecting brain…”
Saadati, H., Gholizadeh, N., Moradikor, N., & Dadkhah, M. (2024) · Neurochemical Journal · doi:10.1134/s1819712424700430
Mancini, G. F., Morena, M., & Campolongo, P. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00020-7
Endocannabinoids regulation of the mesolimbic system
Melis, M., & Brandalise, F. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00011-6
Fu, X., Shelkar, G. P., Coleman, E. M., Antonoudiou, P., Maguire, J. L., & Tasker, J. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.10.693563
“CCK-positive GABAergic interneurons are heterogeneous, including both large-somata, CB1-positive basket cells and small-somata, CB1-negative cells that co-express vasoactive intestinal polypeptide (VIP) (Jasnow et al., 2009; Katona et al., 2001; Mascagni & McDonald, 2003; Vogel et al., 2016).”
van Vuuren, M. J. (2011) · SUNScholar (Stellenbosch University)
Iwanicka, K., Malicki, D., & Olajossy, M. (2014) · Current Problems of Psychiatry
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128189
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128186
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128183
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128177
Miller, D. S., & Wright, K. M. (2021) · Figshare · doi:10.6084/m9.figshare.15128180
Ostos‐Valverde, A., Sánchez‐Zavaleta, R., Téllez-Vega, E. D., Aguilar-Dorado, A., Herrera-Solís, A., Ruiz‐Contreras, A. E., & García, Ó. P. (2026) · Revista Internacional de Investigación en Adicciones · doi:10.28931/riiad.2026.396
Inoshita, T., & Kawaguchi, S.-Y. (2026) · eLife · doi:10.7554/elife.105268.2
McFadden, M. H. (2018) · theses.fr (ABES) · doi:10.70675/036294d9z53a4z495ez9221ze4fba667c298
Rôles des récepteurs cannabinoïdes de type 1 dans le cortex piriforme antérieur
Terral, G. (2018) · theses.fr (ABES) · doi:10.70675/e2f2a12dzf4e6z4340z969fz663bd036cd94
Reelin in vulnerability and sex-dependent maturational trajectories of the prefrontal cortex
Silva-Hurtado, T. J. (2021) · theses.fr (ABES) · doi:10.70675/ecf0031ez1ac8z4688za735za4cd9acfc52c
Decoding the Toxicity of Synthetic Cannabinoids: From Receptor Activation to Multiorgan Dysfunction
Fan, W., Che, Z., Xiao, L., Shi, K., Meng, Q., Yang, L., Yao, L., Ye, Y., Wei, Y., & Liao, L. (2026) · Medicinal Research Reviews · doi:10.1002/med.70073
Luan, Y., Wang, S., Gao, Y., Kong, Q., Ma, Z., & Luan, C. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1915122
“Anatomical work in the amygdala further demonstrates that CB1R expression is distributed across speci fi c nuclei and presynaptic cellular elements rather than forming a uniform regional signal (102).”
Heemann, F. (2026) · Psychoactives · doi:10.3390/psychoactives5040029
Novel roles of the endocannabinoid system in modulating synaptic plasticity
Angell, A. N. (2008) · The Mathematics Enthusiast
Metadata
- Authors
- Katona, I., Rancz, E. A., Acsády, L., Ledent, C., Mackie, K., Hájos, N., & Freund, T. F.
- Affiliations
- HUN-REN Institute of Experimental Medicine (HU)
- Université Libre de Bruxelles (BE)
- University of Washington (US)
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2001-12-01
- Volume
- 21
- Issue
- 23
- Pages
- 9506-9518
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6763903
- OpenAlex
- W2153392906
- Cited by
- 668
- References
- 59
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 18 · 2023: 20 · 2022: 31 · 2021: 29 · 2020: 33 · 2019: 18 · 2018: 20 · 2017: 36 · 2016: 37 · 2015: 34 · 2014: 27 · 2013: 29 · 2012: 26
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Hungarian Scientific Research Fund (T032251)
- National Institutes of Health (5k01da000285-04)
- National Institute on Drug Abuse (DA 00285, DA11322, R01DA011322)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 41301, P30DK041301)
- National Institute of Neurological Disorders and Stroke (NS30549)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- CB1 receptor, amygdala, GABAergic neurotransmission, cholecystokinin interneurons, presynaptic modulation, endocannabinoids, lateral amygdala, basal amygdala, cannabinoid receptor agonists, CB1 knockout mice, emotional behavior
- MeSH terms
- Amygdala, Analgesics, Animals, Cannabinoids, Cholecystokinin, Cyclohexanols, gamma-Aminobutyric Acid, Interneurons, Male, Membrane Potentials, Morpholines, Naphthalenes, Nerve Net, Neural Inhibition, Synaptic Transmission, Organ Specificity, Receptors, Drug, Receptors, GABA-A, Rats, Wistar, Presynaptic Terminals, Mice, Knockout, Patch-Clamp Techniques, Receptors, Cannabinoid, Benzoxazines, Mice, Rats, Cannabinoid Receptor Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
